United Therapeutics News and Activities

United Therapeutics is one of the...

• Forbes Global 2000 (#1485);
• Russell 3000;
• TOB Iconic 10,000.

United Therapeutics is a company listed under the stock ticker UTHR (US).

View the org chart displaying its 33 main executives

Most searched biographies at United Therapeutics

• Martine Rothblatt, Chairman of the Board and Chief Executive Offic...
• Ray Kurzweil, Director
• Linda Maxwell, Independent Director

Popular executive movements at United Therapeutics

• Raymond Dwek, Director, will retire in Jun. 2026  (posted on April 30 2026).
• Kevin Tracey has joined the company as Director  (posted on January 22 2026).
• Andrea Christopher has joined the company as Senior Director, Corporate Communications  (posted on November 7 2025).

Create your alert
to follow the executive moves at United Therapeutics.

United Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by United Therapeutics

• United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference
• United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026
• United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference
• United Therapeutics Corporation Reports First Quarter 2026 Financial Results
• United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors
• United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026
• United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
• United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure
• United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2
• United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program
• View more press releases Close

Social media about United Therapeutics

• United Therapeutics on Wikipedia, Google News & Yahoo Finance
• United Therapeutics on LinkedIn, X (Twitter) & YouTube